Insights from 2023 EHA® Annual Meeting

 

Insights from 2023 EHA® Annual Meeting
G

EHA® 2023 Insights: "ATLAS-PPX, A Ph3 Study of Fitusiran in People With Hemophilia A or B Who Have Switched From Prior Factor or Bypassing Agent Prophylaxis"

By Insights from 2023 EHA® Annual Meeting FEATURING Guy Young
By Insights from 2023 EHA® Annual Meeting FEATURING Guy Young
52 views
June 14, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
Benign Hematology
14:32
Insights from 2023 EHA® Annual Meeting

EHA® 2023 Insights: "Preliminary Results From the Ph1/2 RUBY Tr…

Feat. R. Hanna
07:48
Insights from 2023 EHA® Annual Meeting

EHA® 2023 Insights: "ATLAS-PPX, A Ph3 Study of Fitusiran in Peo…

Feat. G. Young